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Abstract HERC proteins are characterized by having one or
more RCC1-like domains as well as a C-terminal HECT do-
main in their amino acid sequences. This has led researchers to
suggest that they may act as both guanine nucleotide exchange
factors and E3 ubiquitin ligases. Here we describe a physical
interaction between the HECT domain of HERC1, a giant pro-
tein involved in intracellular membrane tra⁄c, and the M2 iso-
form of glycolytic enzyme pyruvate kinase (M2-PK). Partial
colocalization of endogenous proteins was observed by immuno-
£uorescence studies. This interaction neither induced M2-PK
ubiquitination nor a¡ected its enzymatic activity. The putative
signi¢cance of the association is discussed.
/ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The human HERC protein family consists of four proteins
sharing a HECT domain in their carboxyl-termini and one or
more RCC1-like domains (RLDs) elsewhere in their amino
acid sequences. The HECT domain (homologous to E6-AP
carboxyl-terminus) was ¢rst characterized as the domain in-
volved in the E6-AP-mediated ubiquitination of p53 in the
presence of papillomaviral E6 oncoprotein [1]. More gener-
ally, HECT domains are assumed to confer E3 ubiquitin-pro-
tein ligase activity to those proteins containing them through
a mechanism involving formation of a thioester bond between
ubiquitin’s carboxyl-terminus and a conserved active site cys-
teine residue in the HECT [2,3]. The RCC1-like domain, on
the other hand, was initially identi¢ed in the regulator of
chromosome condensation-1 (RCC1) protein, where it has
been shown to stimulate GDP/GTP exchange upon Ran, a
monomeric G-protein belonging to the Ras superfamily of
GTPases, and thus to regulate important cellular processes
such as nucleocytoplasmic transport and mitotic spindle for-
mation [4,5]. For this reason, it is thought that RLDs may act
as guanine nucleotide exchange factors (GEFs) for small
GTPases [6].
The HERC family can in turn be divided into two subfam-
ilies: the large HERCs (HERC1 and HERC2) are giant pro-
teins almost 5000 amino acid residues long, encoded in chro-
mosome 15 [7] and possessing at least two RLDs and other
known sequence motifs in addition to the HECT, whereas the
small HERCs (HERC3 and HERC4) are less than one fourth
the size of their larger counterparts, are encoded in chromo-
some 4 [8] and their primary structures display little more
than one RLD and the HECT. Very little is known about
the cellular functions of these proteins. Mouse HERC2, en-
coded in the rjs/jdf2/herc2 locus, has been linked to a genetic
syndrome whose major symptoms include dwar¢sm, a jerky
gait and sterility. Interestingly, all these phenotypes appear to
be due to the loss of function of HERC2’s HECT domain
[9,10]. HERC3 is a cytosolic and inner membrane-associated
protein which has recently been shown to bind non-covalently
to ubiquitin as well as to undergo ubiquitin-mediated protea-
somal degradation [11]. HERC4 (also called Ceb-1) was iso-
lated in a yeast two-hybrid screening using both cyclin E and
p21 as baits. Unlike all other HERCs whose expression is
rather ubiquitous, HERC4 is selectively expressed in repro-
ductive tissues and undergoes upregulation when the functions
of both p53 and pRB tumor suppressors are compromised
[12]. HERC1, the largest family member (532 kDa) and the
¢rst to be described, contains a number of conserved sequence
features which are supposed to play di¡erent roles in the over-
all function(s) of the protein. HERC1 possesses two RLDs
(RLD1 and RLD2) which have been implicated in di¡erent
cellular tasks: while RLD1 stimulates guanine nucleotide dis-
sociation on several ARF and Rab family GTPases [6], RLD2
forms a ternary complex with clathrin heavy chain and the
chaperone Hsp70 [13]. These data, together with HERC1’s
localization in inner cell membranes such as the Golgi appa-
ratus and the cytosol [6], have led to the suggestion that this
protein has an important function in intracellular membrane
tra⁄c. In addition to its RLDs, the most relevant conserved
regions in HERC1 include a SPRY (repeats in splA and RyR)
domain, a WD-40 domain, both thought to mediate protein^
protein interactions [14,15], an F-box motif that might ac-
count for HERC1 being a constituent of a so far unidenti¢ed
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SCF E3 ubiquitin ligase complex [15,16], three putative SH3
binding sites and, ¢nally, the HECT domain, which has al-
ready been shown to bind ubiquitin in a dithiothreitol-sensi-
tive manner, thus con¢rming its ability to act as an E3 ubiq-
uitin-protein ligase [17].
All the above-stated conserved regions present in HERC1
have already been involved in the formation of heteromolec-
ular complexes through protein^protein interactions. In order
to identify proteins that interact with HERC1, we have used
several HERC1 domains as baits in the yeast two-hybrid sys-
tem. In this study, we report the identi¢cation of M2-type
pyruvate kinase as a protein that interacts with the HECT
domain of HERC1.
2. Materials and methods
2.1. Plasmids
The 5P-untranslated region of HERC1 cDNA was removed from
previously described plasmid pJLR75 [6] by ¢rst amplifying a poly-
merase chain reaction (PCR) fragment in the 5P-coding region with
oligos SEQJL135 (5P-CCATCGATGAATTCAACATGGCAACTA-
TGATTCCA-3P) and SEQJL057 (5P-CTTCTCCGAAAGAGGCCA-
TA-3P) and then ligating the ClaI^NdeI-digested PCR fragment with
the larger fragment resulting from digestion of pJLR75 with the same
restriction enzymes. This new plasmid was called pFG1 and was used
to generate pFG3 by subcloning its EcoRI insert into pcDNA3.1/HisC
(Invitrogen). pJLR82 was created by cloning into pGBT9 (Clontech) a
BamHI^SalI-digested DNA fragment obtained by PCR ampli¢cation
of pJLR75 with oligos SEQJL118 (5P-CGGGATCCCGAGACAAG-
TAGTTAAGCTG-3P) and SEQJL119 (5P-ACGCGTCGACGGT-
CAGTAGTCAGTGTCG-3P). EcoRI^SalI insert was extracted from
pJLR82 and subcloned into both EcoRI^SalI-digested pFastBacHTa
(Invitrogen) and EcoRI^XhoI-cut pcDNA3.1/HisC to form plasmids
pFG26 and pCC44, respectively. pFastBacHTa digested with RsrII
and EcoRI was ligated with a DNA fragment produced by PCR-
amplifying vector pGEX4T1 (Amersham Pharmacia Biotech) with
oligos RsrIIGST (5P-CTCGGTCCGAAACCATGTCCCCTATAC-
TAGGT-3P) and GSTThr (5P-GGGAATTCCGGGGATCCACGCG-
GAACCAG-3P) followed by digestion with the same restriction endo-
nucleases. The resulting plasmid, pFastBacGSTa, was subsequently
used to create another plasmid, pPM7, by introducing into the former
the EcoRI insert from pFG1. pJDD7 was similarly created through
ligation of the 4 kb BamHI^EcoRI fragment of pFG1 with BamHI^
EcoRI-restricted pFastBacGSTa. pJDD8 and pJDD9 were generated
by digesting pPM7 with either SpeI (pJDD8) or XhoI (pJDD9) fol-
lowed by religation of the vector-containing fragments. pFG32 was
obtained by transferring the SmaI^XhoI insert from pClone25 (see
Section 3) into pGEX4T1. pT7-7-His-UbcH5a was provided by Dr.
Kazuhiro Iwai.
2.2. Yeast two-hybrid experiments
Yeast experiments were carried out according to Matchmaker Gal4
Yeast Two-Hybrid System-3 (Clontech). Brie£y, Saccharomyces cere-
visiae AH-109 cells were cotransformed with pJLR82 (encoding
HERC1’s last 366 amino acid residues) and a HeLa cell cDNA library
cloned into pGAD-GH vector (Clontech). Transformants were seeded
on appropriate selective media in order to isolate positive clones and
library plasmids were isolated from these by complementation of the
leuB6 mutation of Escherichia coli MH4 strain. For ¢lter L-galactosi-
dase assays see [13].
2.3. Antibodies
Mouse monoclonal anti-M2-PK (clone DF4) was from ScheBo Bi-
otech (Giessen, Germany). Mouse monoclonal anti-His (clone His-1)
and anti-glutathione-S-transferase (GST) were from Sigma, as was
rabbit anti-ubiquitin antiserum. A⁄nity puri¢ed rabbit polyclonal
antibodies against HERC1 (410 and 417) have already been described
elsewhere [6].
2.4. Baculoviruses, protein puri¢cation and pull-down experiments
2.4.1. Baculoviruses. Recombinant baculoviruses expressing His-
HECT, GST, GST-HERC1 (amino acid residues (aa) 1^1413) GST-
HERC1 (aa 1^3716), GST-HERC1 (aa 1^4861, full length) and GST-
HERC1 (aa 3684^4861) were generated from plasmids pFG26, pFast-
BacGSTa, pJDD9, pJDD8, pPM7 and pJDD7, respectively. All these
baculoviruses were produced according to the Bac-to-Bac system’s
instructions manual (Invitrogen). M2-PK baculovirus was provided
by Dr. Tamio Noguchi.
2.4.2. Protein puri¢cation. Nickel-NTA agarose beads (Qiagen)
were used to purify both His-UbcH5a from E. coli BL21 cells trans-
formed with plasmid pT7-7-His-UbcH5a and His-HECT from bacu-
lovirus-infected Sf9 cells. Likewise, GST-M2-PK (aa 406^531) ex-
pressed by pFG32-transformed E. coli XL1 blue cells, GST and
GST-HERC1 (full length) from Sf9 cells were isolated using gluta-
thione-Sepharose 4B beads (Amersham Pharmacia Biotech). Bacterial
puri¢cations were carried out according to standard procedures. In-
sect cell puri¢cations were done basically as described in [6].
2.4.3. Pull-down experiments. In vitro pull-down experiments were
performed by mixing in phosphate-bu¡ered saline (PBS) 0.5 Wg of
either GST or GST-M2-PK (aa 406^531), both bound to gluta-
thione-Sepharose beads, and 1.2 Wg of soluble His-HECT. After 3 h
of rocking at 4‡C, beads were washed three times in PBS and then
subjected to sodium dodecyl sulfate^polyacrylamide gel electrophore-
sis (SDS^PAGE)/immunoblot analysis. In vivo pull-down experiments
were carried out 72 h after Sf9 cells had been infected with appro-
priate baculoviruses. Cells were lysed in V1 ml/5U106 cells of bu¡er
containing 20 mM Tris^HCl, pH 7.5, 150 mM NaCl, 1% (v/v) Non-
idet P-40, 5 mM L-mercaptoethanol, 5 mM imidazole, 1 mM phenyl-
methylsulphonyl £uoride, 1 Wg/ml pepstatin A, 5 Wg/ml aprotinin and
5 Wg/ml leupeptin and centrifuged 20 min at 15 000Ug. 50 Wl of either
glutathione-Sepharose or nickel-NTA-agarose beads per ml superna-
tant were then added and the resulting mixture was rocked for 2 h.
Beads were washed three times with lysis bu¡er containing 300 mM
NaCl and once with lysis bu¡er (no protease inhibitors in washes).
Pulled-down proteins were studied by SDS^PAGE/immunoblot. The
pull-down in Fig. 1E was performed by mixing 100 ng of bead-bound,
puri¢ed GST or GST-HERC1 and 5 ml of an M2-PK-expressing Sf9
cell lysate (lysis as above). The mixture was rocked for 2 h and beads
washed four times with lysis bu¡er before being analyzed by SDS^
PAGE/immunoblot.
2.5. Cell culture and transfection
HEK-293T and HeLa cells were maintained as described in [11].
Transfection of HEK-293T was achieved using the calcium phosphate
method when cells were at a con£uence of 40^70%. Experiments were
performed 40 h after cells were transfected. Sf9 cells were cultured in
Petri dishes at 27‡C with insect cell medium (BioWhittaker) to which
10% fetal bovine serum was added. Baculovirus infections were car-
ried out using standard procedures.
2.6. Confocal immuno£uorescence microscopy
HeLa and HEK-293T cells were grown on glass coverslips and
processed as described in [11]. Dilutions used were 1/25 and 1/200
for anti-M2-PK and anti-HERC1 (410) antibodies, respectively. Sec-
ondary antibodies were £uorescein-isothiocyanate (FITC)-conjugated
goat anti-rabbit IgGs and Texas red-isothiocyanate-conjugated goat
anti-mouse IgGs (both from Amersham Pharmacia Biotech). Samples
were observed under a Leica TCS-NT confocal microscope.
2.7. Ubiquitination experiments and enzyme activity measurements
LLnL experiments in HEK-293T cells were performed as previously
described [11]. In order to measure pyruvate kinase activity in HEK-
293T cells, these were ¢rst placed on ice, washed once with ice-cold
PBS and extracted in a bu¡er containing 10 mM Tris^HCl, pH 7.4,
1 mM NaF, 1 mM ethylenediamine tetraacetic acid (EDTA) and 1 mM
L-mercaptoethanol. Cells were then lysed with a cell homogenizer and
total cell extracts centrifuged 20 min at 15 000Ug. Supernatants were
then taken and used both to measure total protein levels (BCA kit,
Pierce) and to carry out activity assays. These were done in a bu¡er
containing 50 mM Tris^HCl, pH 7.6, 100 mM KCl, 5 mM MgSO4,
2 mM ADP, 0.2 or 2 mM phosphoenolpyruvate (PEP), 0.25 mM
NADH and 0.15 mg/ml lactate dehydrogenase (Roche Molecular Bio-
chemicals). Activity was calculated by monitoring the absorbance fall
at 340 nm. The e¡ect of UbcH5 on M2-PK activity (Fig. 3C) was
determined by adding 2 ng of His-UbcH5a per Wg total protein to the
HEK-293T extracts followed by a 30-min incubation at 4‡C prior to
activity measurements.
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3. Results
3.1. HERC1^M2-PK interaction in the yeast two-hybrid
system
A yeast two-hybrid screening was performed using the last
366 amino acid residues of HERC1 (aa 4496^4861), encom-
passing its HECT domain, as bait. Plasmid pJLR82 encoding
the aforementioned HERC1 fragment fused to Gal4 DNA
binding domain was transformed into S. cerevisiae AH-109
cells together with a library constructed by inserting HeLa
cell cDNAs into EcoRI^XhoI targets of vector pGAD-GH,
which encodes Gal4 transcriptional activation domain. Posi-
tive clones were selected by their ability to grow in the absence
of histidine, adenine, leucine and tryptophan. Most positives
obtained in this manner turned out to possess a library insert
corresponding to the C-terminal region (aa 406^531) of gly-
colytic isoenzyme pyruvate kinase type M2. This interaction
was con¢rmed by a ¢lter L-galactosidase assay (Fig. 1A). The
fact that M2-PK failed to interact with HERC3, a homologue
of HERC1, appears to indicate that this interaction is speci¢c
for HERC1 and does not take place with other HERC family
members. On the other hand, neither pJLR82 nor pClone25
(pGAD-GH with the M2-PK insert) gave rise to L-galþ cells
when transformed together with empty pGAD-GH or pGBT9
vectors, respectively.
3.2. In vitro pull-down experiments
In order to con¢rm the yeast two-hybrid interaction as well
as to check whether this was direct or else might be mediated
by a bridging protein, histidine-tagged HERC1 (aa 4496^
4861, henceforth also referred to as His-HECT) and GST-
M2-PK (aa 406^531) fusion protein were puri¢ed and pull-
downs were carried out with glutathione-Sepharose beads
(Fig. 1B, see also Section 2). Results show clearly that His-
HECT binds to GST-M2-PK (406^531) and does not to GST,
from which it can be concluded that the interaction exists and
is likely to be direct between the two proteins.
3.3. In vivo pull-down experiments in insect cells
Next, HERC1^M2-PK interaction was studied in vivo in
baculovirus-infected Sf9 insect cells. First, cells were infected
with baculoviruses encoding full-length M2-PK and His-
HECT and lysates pulled-down with nickel beads (Fig. 1C).
When this was done, a fraction of M2-PK was found in the
beads, whereas none could be found when pull-downs were
carried out in control cells expressing only M2-PK and not
His-HECT, indicating that M2-PK bound speci¢cally to His-
HECT. Second, full-length M2-PK was heterologously ex-
pressed either alone or together with GST or three GST fu-
sion proteins encompassing the entire length of HERC1 and
cell extracts were pulled-down with glutathione beads. As ex-
pected, M2-PK could only be detected in the beads when it
was coexpressed with the fusion protein containing HERC1’s
carboxyl-terminal region (GST-HERC1 (3684^4861)) and not
in all other conditions (Fig. 1D). Finally, we attempted to ¢nd
the interaction between both full-length proteins. In order to
achieve this goal, we incubated puri¢ed, bead-bound GST or
GST-HERC1 (aa 1^4861, full-length protein) with an M2-PK
baculovirus-infected Sf9 cell lysate. Immunoblot analysis
showed that a small fraction of M2-PK bound to GST-
HERC1 beads, whereas none could be found in control
GST beads (Fig. 1E). Taken together, these results demon-
strate that M2-PK and HERC1, through its HECT domain,
have the ability to interact with each other.
3.4. Immuno£uorescence analysis of HERC1^M2-PK
colocalization
Subcellular localization of endogenous HERC1 and M2-PK
proteins was studied by indirect immuno£uorescence confocal
microscopy in HeLa and HEK-293T cell lines (Fig. 2). It is
noteworthy that both proteins display a similar, mostly peri-
nuclear, punctate staining, which probably means that these
proteins somehow interact with membranous intracellular
structures in these cell lines [18]. Furthermore, colocalization
analysis shows a partial overlapping in the subcellular distri-
butions of both proteins, as seen by the appearance of yellow
dots when stainings are superimposed.
3.5. Analysis of M2-PK ubiquitination
In view of the fact that HERC1 is very likely to be an E3
ubiquitin-protein ligase (it possesses a HECT domain and an
F-box motif, both generally recognized as hallmarks of such
enzymes), we checked whether M2-PK might be a ubiquitina-
tion substrate of HERC1. Nevertheless, since ubiquitination
of M2-PK has not been described, we ¢rst set about deter-
mining whether M2-PK undergoes ubiquitination under phys-
iological conditions. For this purpose, we analyzed the e¡ect
of proteasome inhibitor N-acetyl-leucyl-leucyl-norleucinal
(LLnL) on M2-PK protein levels in HEK-293T cells (Fig.
3A). While LLnL induced the accumulation of ubiquitinated
forms of other proteins, this was not observed for M2-PK nor
were its levels a¡ected, as would have been expected of a
proteasomally degraded protein. These results notwithstand-
ing, the possibility remained that M2-PK underwent non-
proteasome-coupled ubiquitination. To test this hypothesis,
histidine-tagged ubiquitin was transfected into HEK-293T
cells and cell lysates were incubated with nickel beads to
pull-down His-ubiquitinated proteins. Immunoblot analysis
showed that M2-PK was not among them (data not shown).
Moreover, transcription and translation of radiolabeled M2-
PK in rabbit reticulocyte lysates followed by addition of GST-
ubiquitin did not result in formation of GST-ubiquitin^M2-
PK adducts (data not shown). All results, therefore, point to
the direction that M2-PK does not undergo ubiquitination
and thus cannot be a ubiquitination substrate of HERC1.
3.6. E¡ect of HERC1 upon M2-PK enzyme activity
In order to analyze whether the HECT domain of HERC1
might modulate M2-PK enzyme activity, HEK-293T cells
were transfected with either control plasmid (pcDNA3.1/
His) or plasmid encoding His-HECT (pCC44). His-HECT
expression was con¢rmed by immunoblot (data not shown).
Activity was measured in cell lysates at two di¡erent phos-
phoenolpyruvate (PEP) concentrations: 0.2 mM (correspond-
ing roughly to the concentration at which M2-PK has half-
maximal activity (SPEP0:5 = 0.25 mM) [19]) and 2 mM, a saturat-
ing PEP concentration. In this manner, we intended to distin-
guish between e¡ects upon M2-PK’s a⁄nity for PEP and
e¡ects upon its Vmax. However, as it can easily be grasped
from Fig. 3B, none of those e¡ects were observed. It might
be, though, that the HECT domain alone is not su⁄cient to
induce any alterations in M2-PK activity and that full-length
HERC1 is needed for them to occur. To test this, we mea-
sured M2-PK activity in extracts from control and HERC1-
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Fig. 1. Interaction between HERC1 and M2-PK. A: The last 366 amino acid residues of HERC1 were used as bait in the yeast two-hybrid system. Among all positive clones analyzed, most cor-
responded to the last 126 amino acid residues of pyruvate kinase type M2. Top: Schematic representations of HERC1 and M2-PK proteins have been drawn to scale. Major HERC1 domains
have also been depicted. M2-PK’s active site is marked with an arrowhead. Interacting regions in both proteins have been underlined. Bottom: Filter L-galactosidase assay. Three independent
clones are shown for each condition. (1) Interaction between HERC1 (aa 4496^4861) and M2-PK (aa 406^531). (2) SNF1^SNF4 interaction as positive control. (3) Interaction is speci¢c for
HERC1, since it doesn’t take place with HERC3. (4^5) Negative controls. B: Left: Coomassie blue staining showing puri¢cations of GST-M2-PK (406^531) and His-HECT proteins. The lower
band in the former is a degradation product. Right: In vitro pull-downs con¢rmed the yeast interaction. Pulled-down GST and GST-M2-PK (406^531) and the His-HECT associated to them
were resolved by SDS^PAGE and analyzed by immunoblot. Bottom right: 4% of the His-HECT used in pull-downs was loaded into another gel and immunoblotted as well. C: Immunoblots of
Sf9 cells infected with baculoviruses encoding full-length M2-PK and His-HECT as indicated. When His-HECT was pulled-down with nickel beads, M2-PK was also found associated. D: Re-
combinant baculoviruses expressing M2-PK, GST and three GST fusion proteins encompassing the whole HERC1 protein were used to infect Sf9 cells as indicated. Cell extracts were pulled-
down with glutathione beads and associated proteins analyzed by SDS^PAGE/immunoblot. M2-PK only interacted with the fusion protein containing HERC1’s HECT domain. Top left: M2-
PK bound to pulled-down GST fusion proteins. Bottom left: M2-PK levels in cell extracts. Right: Pulled-down GST fusion proteins. E: Glutathione-Sepharose beads bound to either GST or
GST-HERC1 (aa 1^4861, full length) were incubated with a lysate from M2-PK baculovirus-infected Sf9 cells and beads were analyzed by SDS^PAGE/immunoblot. A small amount of M2-PK
was speci¢cally pulled-down by full-length HERC1.
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overexpressing HEK-293T cells (immunoblot analysis showed
a 2^3-fold overexpression, data not shown). As shown in Fig.
3C, no signi¢cant changes were detected. Moreover, since
HERC1 is known to form a thioester bond with ubiquitin
in the presence of UbcH5 [17], we also checked whether the
latter protein was necessary for an e¡ect to take place. Never-
theless, addition of puri¢ed His-UbcH5a to the former ex-
tracts had no e¡ect whatsoever on M2-PK enzyme activity
(Fig. 3C). We also wondered whether HERC1 might have
an e¡ect upon M2-PK’s dimer-to-tetramer ratio, as do other
proteins such as papillomaviral protein E7 [19]. To address
this issue, we loaded control, His-HECT-expressing and
HERC1-overexpressing HEK-293T lysates into a gel ¢ltration
chromatography column in order to separate dimeric and tet-
rameric M2-PK. Elution pro¢les did not show any signi¢cant
di¡erences between those samples (data not shown). In sum-
mary, all these results appear to indicate that HERC1 does
not a¡ect M2-PK enzyme activity.
4. Discussion
In the present study, we have shown a physical interaction
between HERC1, a protein involved in intracellular mem-
brane tra⁄c, and glycolytic isoenzyme M2-PK. This interac-
tion was ¢rst found in the yeast two-hybrid system and it was
shown to take place between the last 366 amino acid residues
of HERC1, which encompass its HECT domain, and the last
126 residues of M2-PK including critical residues involved in
fructose-1,6-bisphosphate binding and intersubunit contact
(see below). The interaction was subsequently demonstrated
to be direct by in vitro pull-down assays carried out with
puri¢ed proteins and to occur in vivo in Sf9 insect cells
when both full-length M2-PK and the last 366 or 1178 amino
acid residues of HERC1 were expressed using recombinant
baculoviruses. An interaction between both full-length pro-
teins, albeit weak, could also be demonstrated in pull-down
experiments in Sf9 cells. Moreover, human endogenous
HERC1 and M2-PK proteins were shown to display similar,
partially overlapping, perinuclear, punctate stainings when
their subcellular localization was analyzed by immuno£uores-
cence microscopy. This presumably indicates that both pro-
teins are associated with intracellular membranous compart-
ments [18] and is in agreement with previous data reporting
M2-PK activation by phosphatidylserine-containing lipo-
somes [20] and HERC1 localization in inner cell membranes
[6]. However, in spite of all this evidence, we have failed to
pinpoint the HERC1^M2-PK interaction in mammalian cells.
Several reasons might explain this. One of them is the lack of
good commercial antibodies to immunoprecipitate endoge-
nous M2-PK or HERC1 proteins. Another possible reason
may have to do with the low levels of expression achieved
when full-length tagged HERC1 (His-HERC1 or Myc-
HERC1) was transfected into mammalian cell lines (HeLa,
HEK-293T, COS-1), which in turn is likely to be due to
HERC1’s giant size (4861 aa). Interestingly, we also could
not ¢nd the interaction by immunoprecipitation of Myc-
HERC1 (aa 3684^4861) or by pull-down of His-HERC1 (aa
4496^4861) in mammalian cells. In our opinion, these data
probably indicate that M2-PK binding to HERC1 is tightly
regulated in mammals and only happens under very speci¢c
conditions.
M2-PK undergoes a very complex regulation. Since it cata-
lyzes the last step in glycolysis, the regulation of its activity is
essential for cells to control the amount of carbon channeled
into energy production (anaerobic glycolysis or the TCA
cycle) and into biosynthetic pathways (M2-PK inhibition in-
Fig. 2. Localization of endogenous HERC1 and M2-PK proteins was analyzed by confocal immuno£uorescence microscopy in HeLa and
HEK-293T cell lines. Both proteins display a perinuclear, punctate staining that presumably indicates their association with intracellular mem-
branous structures. HERC1 and M2-PK show a partial colocalization in both cell lines when images are overlaid. All images correspond to
one single cellular plane.
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duces an accumulation of glycolytic phosphometabolites that
may act as biosynthetic precursors [21]). As a matter of fact,
M2-PK is only one of four pyruvate kinase isoenzymes in
mammals, the other three being L-PK, R-PK and M1-PK.
The ¢rst two are expressed in liver and red blood cells, re-
spectively, and arise from a single gene (the PKL gene) by
di¡erential promoter use. M1-PK, on the other hand, is
mainly expressed in muscle and brain and is characterized
by its hyperbolic Michaelis^Menten kinetics, in opposition
to all other isoforms, which display sigmoidal kinetics. M1-
and M2-PK are also synthesized from a single common gene
(the PKM gene), which by di¡erential splicing gives rise to the
two proteins (these di¡er only in a short stretch of 56 amino
acid residues corresponding to the alternatively spliced exon)
[22,23]. M2-PK, like L-PK and R-PK, is allosterically regu-
lated via feed-forward activation by fructose-1,6-bisphosphate
(FBP) and via feedback inhibition by adenosine triphosphate
(ATP) [21]. Furthermore, M2-PK can be found in cells in two
major forms, namely, a highly active tetramer and a less active
dimer. The equilibrium between these two forms can be
shifted towards one or the other side by several factors:
thus, while FBP induces tetramer formation, tyrosine phos-
phorylation or the E7 oncoprotein of carcinogenic human
papillomaviruses inactivate the enzyme by converting it into
the dimeric form [21,24]. All these regulatory properties, es-
pecially its ability to ¢ne-tune the relative levels of energy
production and biosynthesis, appear to make M2-PK the
most suitable PK isoform for proliferating cells, which have
high energetic and biosynthetic requirements at the same time.
This would explain why M2-PK is expressed in all tissues
during development and also why it is re-expressed when cells
de-di¡erentiate to become malignant or, still, why it is tar-
geted by viral oncoproteins [19,23,24]. In fact, dimeric M2-
PK, also known as tumor M2-PK, accumulates in malignant
cells and has even turned out to be a good diagnostic marker
for a number of cancers [25].
Any of these processes a¡ecting M2-PK function could be
regulating its interaction with HERC1. In this regard, we
checked whether binding could be dependent on M2-PK being
phosphorylated in tyrosine residues, which is known to inac-
tivate the enzyme and could also shed some light on a possible
role of HERC1 in tumorigenesis suggested by the fact that
this protein is overexpressed in tumor cell lines [6]. Nonethe-
less, neither expression in HEK-293T cells of constitutively
active Src (v-Src is known to be involved in tyrosine phos-
phorylation of M2-PK in chicken embryos [24]) nor epidermal
growth factor treatment of A431 cells induced the association
of both proteins (data not shown). It might also be that the
interaction is somehow controlled by FBP levels, but this
hypothesis, which is all the more reasonable in view of the
fact that the HERC1 binding region in M2-PK includes many
critical residues for FBP binding and intersubunit contact [26^
28], still remains to be explored, as is the case for a possible
role of the association of M2-PK to intracellular membranes.
Finally, we attempted to ¢nd a possible physiological sig-
ni¢cance for the interaction. In view of all available informa-
tion about these proteins, it is reasonable to think that
HERC1 could function as an E3 ubiquitin-protein ligase for
M2-PK and/or modulate M2-PK enzyme activity. We tested
both possibilities. First, since we were not able to ¢nd any
ubiquitinated forms of M2-PK nor an increase in its expres-
sion levels in response to a proteasome inhibitor, we con-
Fig. 3. A: Proteasome inhibitor LLnL does not a¡ect M2-PK levels
in HEK-293T cells. Immunoblot analysis showed that while other
proteins became mono- or polyubiquitinated as a result of LLnL
treatment, M2-PK did not undergo this modi¢cation nor were its
protein levels signi¢cantly a¡ected. B and C: M2-PK activity in
HEK-293T cells is not a¡ected by HERC1. B: Activity was ana-
lyzed in cells transfected with either control plasmid or a plasmid
expressing His-tagged HERC1’s HECT domain. C: Activity was an-
alyzed in cells transfected with either control plasmid or a plasmid
expressing full-length His-HERC1 (pFG3) in the absence or pres-
ence of UbcH5a. Activity was measured at two di¡erent phospho-
enolpyruvate concentrations and has been expressed as units per mg
of protein in the extracts (meanXS.E.M. of six independent experi-
ments).
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cluded that M2-PK could not be a ubiquitination substrate of
HERC1. On the other hand, overexpression of HERC1 or its
HECT domain did not a¡ect PK activity in HEK-293T cell
lysates, nor did it alter its dimer-to-tetramer ratio. This activ-
ity is due only or almost only to the M2-PK isoform, since
HEK-293T is an immortalized cell line [23]. Further insight
into the functions of both HERC1 and M2-PK will still have
to be gained before the physiological relevance of their inter-
action can be elucidated.
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